Shan Ahmed Khan

As a journalist focused on finance and the stock market, he delivers fast, reliable, and easy-to-understand coverage of market news.

Commonwealth Bank of Australia Stock (ASX:CBA) Update: Share Price Dips on 15 December 2025 as Rate-Hike Talk Returns and ASB Faces NZ AML Court Action

Commonwealth Bank of Australia Stock (ASX:CBA) Update: Share Price Dips on 15 December 2025 as Rate-Hike Talk Returns and ASB Faces NZ AML Court Action

Commonwealth Bank of Australia (ASX:CBA) started the week under pressure on Monday, 15 December 2025, with its share price slipping alongside a broader pullback in Australian equities. The immediate catalyst was a shift in interest-rate expectations after the Reserve Bank
Exxon Mobil (XOM) Stock Outlook: 2030 Plan Lifts Targets, Analysts Raise Price Goals — What to Watch This Week (Updated Dec. 14, 2025)

Exxon Mobil (XOM) Stock Outlook: 2030 Plan Lifts Targets, Analysts Raise Price Goals — What to Watch This Week (Updated Dec. 14, 2025)

Updated: December 14, 2025Company: Exxon Mobil CorporationTicker: NYSE: XOM Exxon Mobil stock is heading into the new week with fresh momentum—and fresh debate—after the oil major rolled out an upgraded corporate plan through 2030 that sharpened its long-term earnings and
Novo Nordisk Stock (NOVO-B, NVO) Update Dec 14, 2025: Wegovy 7.2 mg Tailwind, Ozempic India Launch, Akero Deal — Outlook for the Week Ahead

Novo Nordisk Stock (NOVO-B, NVO) Update Dec 14, 2025: Wegovy 7.2 mg Tailwind, Ozempic India Launch, Akero Deal — Outlook for the Week Ahead

Updated: December 14, 2025 (Sunday) Novo Nordisk A/S shares ended this week with a rebound after a choppy start, as investors weighed three heavyweight catalysts: (1) the EU regulator’s support for a higher-dose Wegovy, (2) the long-telegraphed India launch of
1 353 354 355 356 357 570
Go toTop